Inhibitory effects of (±)-propranolol on excitation-contraction coupling in isolated soleus muscles of the rat

British Journal of Pharmacology

Volumn 122, Issue 3, 1997, Pages 463-468

  Ha, Tuyen N V ^a   Fryer, Martin W ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

adrenoceptors; ( ) propranolol; (+) propranolol; Excitation contraction coupling; Membrane stabilizing effect; Skeletal muscle

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM ION; POTASSIUM ION; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; POTASSIUM;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; EXCITATION CONTRACTION COUPLING; MALE; MEMBRANE STEADY POTENTIAL; MUSCLE ACTION POTENTIAL; MUSCLE FATIGUE; MUSCLE FIBER MEMBRANE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TONE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SOLEUS MUSCLE; TREMOR; ACTION POTENTIAL; ANIMAL; CELL MEMBRANE POTENTIAL; ELECTROSTIMULATION; IN VITRO STUDY; MUSCLE CONTRACTION; SKELETAL MUSCLE; WISTAR RAT;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CAFFEINE; ELECTRIC STIMULATION; MALE; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; POTASSIUM; PROPRANOLOL; RATS; RATS, WISTAR;

EID: 0030611659     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701405     Document Type: Article

References (22)

1. BENET, L.Z., ØIE, S. & SCHWARTZ, J.B. (1996). The Pharmacological Basis of Therapeutics. ed. Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. & Gilman, A.G., p. 1776, New York: McGraw-Hill.
2. CLEEVES, L. & FINDLEY, L.J. (1984). Beta-adrenoceptor mechanisms in essential tremor: a comparative single concentration study of the effect of a non-selective and a beta-2 selective adrenoceptor antagonist. J. Neurol. Neurosurg. Psychiat., 47, 976-982.
3. CHIARANDINI, D.J. (1980). Curare-like effect of propranolol on rat extraocular muscles. Br. J. Pharmacol., 69, 13-19.
4. COLTART, D. & MELDRUM, S.J. (1971). The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potentials. Arch. Int. Pharmacodyn., 192, 188-197.
5. DULHUNTY, A.F. (1992). The voltage-activation of contraction in skeletal muscle. Prog. Biophys. Molec. Biol., 57, 181-223.
6. DULHUNTY, A.F. & GAGE, P.W. (1985). Excitation-contraction coupling and charge movement in denervated rat extensor digitorum longus and soleus muscles. J. Physiol., 358, 75-89.
7. FINDLEY, L.J. & CAPILDEO, R. (1984). Movement Disorders: Tremor. New York: Oxford University Press.
8. HA, T. & FRYER, M.W. (1995). β-Adrenoceptor antagonists decrease isometric force production in rat slow-twitch skeletal muscles. Proc. Australian Physiol. Pharmacol. Soc., 26, 125P.
9. HA, T. & FRYER, M.W. (1996). Inhibitory effects of (±)-propranolol on excitation and contraction of rat slow-twitch skeletal muscles. Proc. Australian Physiol. Pharmacol. Soc., 27, 163P.
10. HELLENBRECHT, D., LEMMER, B., WIETHOLD, G. & GROBEEKER, H. (1973). Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine β-adrenergic blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol., 277, 211-226.
11. HOWE, R. & SHANKS, G. (1966). Optical isomers of propranolol. Nature, 210, 1336-1338.
12. LARSEN, A. (1978). Effects of pindolol, sotalol and the optical isomers of propranolol on muscle action potentials and depolarization-secretion coupling in the rat. Acta Physiol. Scand., 102, 357-363.
13. LARSEN, A. & TERÄVÄINEN, H. (1978). Effects of the optical isomers of propranolol on neuromuscular transmission in the rat. Exp. Neurol., 59, 435-443.
14. LARSEN, I.A. & TERÄVÄINEN, H. (1982). Propranolol and essential tremor: role of the membrane effect. Acta Neural. Scand., 66, 289-294.
15. MORALES-AGUILERÄ, A. & VAUGHAN WILLIAMS, E.M. (1965). The effects on cardiac muscle of β-receptor antagonists in relation to their activity as local anaesthetics. Br. J. Pharmacol., 24, 332-338.
16. 2+ transport by sarcoplasmic reticulum vesicles. J. Pharmacol. Exp. Ther., 206, 281-288.
17. OGAWA, N., TAKAYAMA, H. & YAMAMOTO, M (1987). Comparative studies on the effects of β-adrenergic blockers in essential tremor. J. Neurol., 235, 31-33.
18. OOTA, I. & NAGAI, T. (1977). Effects of catecholamines on excitation-contraction coupling in frog single twitch fiber. Jap. J. Physiol., 27, 195-213.
19. +)-propranolol on intracellular mechanisms of contraction in striated muscle of the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 194-201.
20. VAN BAAK, M.A., DE HAAN, A., SARIS, W.H., VAN KORDELAAR, E., KUIPERS, H. & VAN DER VUSSE, G.J. (1995). Beta-adrenoceptor blockade and skeletal muscle energy metabolism during endurance exercise. J. Appl. Physiol., 78, 307-313.
21. WESTERBLAD, H. & ALLEN, D.G. (1994). The role of sarcoplasmic reticulum in relaxation of mouse muscle; effects of 2,5-di(tertbutyl)-1,4-benzohydroquinone. J. Physiol., 474, 291-301.
22. ZCHUT, S., FENG, W. & SHOSHANBARMATZ, V. (1996). Ryanodine receptor calcium release channel conformations as reflected in the different effects of propranolol on its ryanodine binding and channel activity. Biochem. J., 315, 377-383.